Therapeutic Anticoagulation with Heparin in Patients with Covid-19

To the Editor: We read with interest the recent Journal articles (Aug. 26 issue) 1,2 about therapeutic anticoagulation in patients with Covid-19. We applaud the investigators for performing rigorous trials to address this important clinical concern in Covid-19. Remarkably, these studies show that th...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The New England journal of medicine 2021-11, Vol.385 (21), p.2013-2014
Hauptverfasser:	Fernandes, Timothy M, McGuire, W. Cameron, Morris, Timothy A, Sterpetti, Antonio V, Zarychanski, Ryan, Lawler, Patrick R, Goligher, Ewan
Format:	Artikel
Sprache:	eng
Schlagworte:	Anticoagulants - adverse effects Blood Coagulation - drug effects Clinical trials Conflicts of interest Coronaviruses COVID-19 Embolism Heparan sulfate Heparin Heparin - adverse effects Hospitalization Humans Infections Pandemics Patients Pulmonary embolisms SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 Thromboembolism
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!